Xilio Therapeutics
35 hedge funds and large institutions have $16.2M invested in Xilio Therapeutics in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
–
Holders Change %
0%
% of All Funds
0.47%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
5
Increased
4
Reduced
11
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
$906K |
| 2 |
Morgan Stanley
New York
|
$982K |
| 3 |
Squarepoint
New York
|
$160K |
| 4 |
UBS Group
Zurich,
Switzerland
|
$163K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
$23.6K |
